Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 12
2 Introduction 14
2.1 What Is This Report About? 14
3 Definitions of
Markets Covered in This Report 15
3.1 In Vitro Diagnostics 15
3.2
Clinical Chemistry Test Reagents 15
3.2.1 Laboratory Reagents 15
3.2.2
Clinical Chemistry Calibrators and Controls 15
3.2.3 Clinical Chemistry
Rapid Tests 15
3.3 Immunochemistry Test Reagents 15
3.3.1 Disease
Specific Markers 15
3.3.1.1 Tumor Markers 15
3.3.1.2 Cardiac Markers
16
3.3.2 Disease Specific Test Reagents 16
3.3.2.1 Auto-Immune Disease
16
3.3.2.2 Rheumatoid Disease 16
3.3.2.3 Anemia/ Vitamins 16
3.3.2.4 Allergy 16
3.3.3 Drug Related Testing Reagents 16
3.3.3.1
Therapeutic Drugs 16
3.3.3.2 Drug of Abuse and Toxicology 17
3.3.4
Hormone Related Testing Reagents 17
3.3.4.1 Specific Proteins 17
3.3.4.2 Fertility and Pregnancy 17
3.3.4.3 Individual/Specified hormones
17
3.3.4.4 Specific Organ Function 17
3.3.5 Immunochemistry
Calibrators and Controls 17
3.3.6 Immunochemistry Rapid Tests 17
3.4
Blood Test Reagents 17
3.4.1 Hematology Test Reagents 17
3.4.1.1
Hematology 18
3.4.1.2 Immunohaematology 18
3.4.1.3 Hematology
Calibrators and Controls 18
3.4.1.4 Immunohaematology Controls 18
3.4.2 Hemostasis Test Reagents 18
3.4.2.1 Hemostasis 18
3.4.2.2
Hemostasis Calibrators and Controls 18
3.4.2.3 Hemostasis Rapid Tests
18
3.4.3 Tissue Typing Reagents 18
3.4.4 Monoclonal Antibodies 19
3.4.5 Cytokines and Immunomodulators 19
3.4.6 Histology and Cytology
Reagents 19
3.5 Microbiology Test Reagents 19
3.5.1 Bacteriology Test
Reagents 19
3.5.1.1 Bacteriology Culture 19
3.5.1.2 Blood Culture
19
3.5.1.3 Bacteriology Identification and Susceptibility 19
3.5.2
Microbiology Calibrators and Controls 19
3.5.3 Microbiology Rapid Tests
20
3.6 Infectious Immunology Test Reagents 20
3.6.1 Bacteriology
20
3.6.2 Virology 20
3.6.2.1 Hepatitis Viruses 20
3.6.2.2
Retroviruses 20
3.6.3 Parasitology 20
3.6.4 Infectious Immunology
Calibrators and Controls 20
3.6.5 Infectious Immunology Rapid Tests 20
3.7 Genetic Test Reagents 20
3.8 Self Testing 21
3.9 Instruments
21
4 Healthcare Sector Review 22
4.1 Healthcare Expenditure 22
4.2
Healthcare Infrastructure 25
4.3 Healthcare Policy 28
4.4 Canada
Healthcare Trade Statistics 29
5 Regulation System 30
5.1 Medical
Equipment Approval Process 30
5.1.1 Classification 30
5.1.2 Conformity
Assessment 31
5.1.2.1 Class II 31
5.1.2.2 Class III 31
5.1.2.3
Class IV 32
5.1.3 License Fee 33
5.1.4 License Application Processing
Duration 33
5.2 Labeling and Packaging 33
5.3 Post-Market Surveillance
34
6 Pricing and Reimbursement 35
7 Distribution Structure 36
7.1
Distribution Structure 36
8 In Vitro Diagnostics In Canada 37
8.1 In
Vitro Diagnostics, Canada, Overall Revenue ($ mn), 2000-2015 37
8.2 In
Vitro Diagnostics, Canada, Company Share (2006-2007) 43
9 Blood Test
Reagents In Canada 44
9.1 Blood Test Reagents Overall Revenue (2000-2015)
44
9.1.1 Haematology Test Reagents Revenue (2000-2015) 48
9.1.2
Hemostasis Test Reagents Revenue (2000-2015) 50
9.2 Blood Test Reagents
Distribution Share (2007-2008) 52
9.3 Blood Test Reagents, Canada, Company
Share (2006-2007) 53
10 Clinical Chemistry Test Reagents In Canada 54
10.1 Clinical Chemistry Test Reagents Overall Revenue (2000-2015) 54
10.2
Clinical Chemistry Test Reagents Distribution Share (2007-2008) 56
10.3
Clinical Chemistry Test Reagents, Canada, Company Share (2006-2007) 57
11
Genetic Test Reagents In Canada 58
11.1 Genetic Test Reagents Overall
Revenue (2000-2015) 58
11.2 Genetic Test Reagents Distribution Share
(2007-2008) 60
11.3 Genetic Test Reagents, Canada, Company Share
(2006-2007) 61
12 Immunochemistry Test Reagents In Canada 62
12.1
Immunochemistry Test Reagents Overall Revenue (2000-2015) 62
12.1.1
Disease Specific Markers Revenue (2000-2015) 66
12.1.2 Disease Specific
Test Reagents Revenue (2000-2015) 68
12.1.3 Drug Related Testing Reagents
Revenue (2000-2015) 70
12.2 Immunochemistry Test Reagents Distribution
Share (2007-2008) 74
12.3 Immunochemistry Test Reagents, Canada, Company
Share (2006-2007) 75
13 Infectious Immunology Test Reagents In Canada
76
13.1 Infectious Immunology Test Reagents Overall Revenue (2000-2015)
76
13.1.1 Virology Revenue (2000-2015) 80
13.2 Infectious Immunology
Test Reagents Distribution Share (2007-2008) 82
13.3 Infectious Immunology
Test Reagents, Canada, Company Share (2006-2007) 83
14 Instruments In
Canada 84
14.1 Instruments Overall Revenue (2000-2015) 84
14.2
Instruments Distribution Share (2007-2008) 86
15 Microbiology Test
Reagents In Canada 87
15.1 Microbiology Test Reagents Overall Revenue
(2000-2015) 87
15.1.1 Bacteriology Test Reagents Revenue (2000-2015)
89
15.2 Microbiology Test Reagents Distribution Share (2007-2008) 91
16 Self Testing In Canada 92
16.1 Self Testing Overall Revenue (2000-2015)
92
16.2 Self Testing Distribution Share (2007-2008) 94
16.3 Self
Testing, Canada, Company Share (2006-2007) 95
17 Overview of Key Companies
in Canada In Vitro Diagnostics Market 96
17.1 F. Hoffmann-La Roche Ltd.
Company Profile 96
17.1.1 Company Overview 96
17.1.2 Value Chain
Analysis 97
17.1.2.1 Manufacturing 97
17.1.2.2 Product Development
97
17.2 Abbott Laboratories Company Profile 99
17.2.1 Company Overview
99
17.2.2 Value Chain Analysis 100
17.2.2.1 Manufacturing 100
17.2.2.2 Product Development 100
17.2.2.3 Sales and Marketing 102
17.3
Beckman Coulter, Inc. Company Profile 103
17.3.1 Company Overview 103
17.3.2 Value Chain Analysis 103
17.3.2.1 Manufacturing 104
17.3.2.2
Product Development 104
17.3.2.3 Sales and Marketing 104
17.3.3
Beckman Coulter, Inc. Pipeline Products 105
17.3.3.1 Beckman Coulter, Inc.
Pipeline Products By Equipment Type 105
17.3.3.2 Beckman Coulter, Inc.
Pipeline Products By Development Stage 106
17.3.3.3 Beckman Coulter, Inc.
Pipeline Products By Therapy Area 106
17.3.3.4 Beckman Coulter, Inc.
Pipeline Products By News Summary 107
17.4 Dade Behring Holdings, Inc.
Company Profile 108
17.4.1 Company Overview 108
17.5 Siemens
Healthcare Company Profile 109
17.5.1 Company Overview 109
17.5.2
Value Chain Analysis 110
17.5.2.1 Manufacturing 110
17.5.2.2 Product
Development 110
17.5.2.3 Sales and Marketing 111
17.6 bioMerieux S.A.
Company Profile 112
17.6.1 Company Overview 112
17.6.2 Value Chain
Analysis 113
17.6.2.1 Manufacturing 113
17.6.2.2 Product Development
114
17.6.2.3 Sales and Marketing 115
17.7 Ventana Medical Systems,
Inc. Company Profile 116
17.7.1 Company Overview 116
17.8
Ortho-Clinical Diagnostics Inc. Company Profile 117
17.8.1 Company
Overview 117
17.8.2 Ortho-Clinical Diagnostics Inc. Pipeline Products
117
17.8.2.1 Ortho-Clinical Diagnostics Inc. Pipeline Products By
Equipment Type 117
17.8.2.2 Ortho-Clinical Diagnostics Inc. Pipeline
Products By Development Stage 117
17.8.2.3 Ortho-Clinical Diagnostics Inc.
Pipeline Products By Therapy Area 118
17.8.2.4 Ortho-Clinical Diagnostics
Inc. Pipeline Products By News Summary 118
17.9 Mindray Medical
International Limited Company Profile 119
17.9.1 Company Overview 119
17.10 Gen-Probe Incorporated Company Profile 120
17.10.1 Company Overview
120
17.10.2 Value Chain Analysis 121
17.10.2.1 Manufacturing 121
17.10.2.2 Product Development 122
17.10.2.3 Sales and Marketing 122
17.10.3 Gen-Probe Incorporated Pipeline Products 123
17.10.3.1 Gen-Probe
Incorporated Pipeline Products By Equipment Type 123
17.10.3.2 Gen-Probe
Incorporated Pipeline Products By Development Stage 123
17.10.3.3
Gen-Probe Incorporated Pipeline Products By Therapy Area 124
17.10.3.4
Gen-Probe Incorporated Pipeline Products By Clinical Trials 124
17.10.3.5
Gen-Probe Incorporated Pipeline Products By News Summary 124
17.11 Digene
Corporation Company Profile 125
17.11.1 Company Overview 125
18
Financial Deals Landscape 126
18.1 Merger 126
18.1.1 Pacgen
Biopharmaceuticals Terminates Merger Agreement with Medigen Biotechnology
126
18.2 Acquisition 127
18.2.1 Cytognomix Receives Investment from
Ontario Genomics Institute 127
18.2.2 JAG Media Holdings to Acquire
CardioGenics from Yahia Gawad 128
18.2.3 Amorfix Life Sciences Receives
Investment from Biogen Idec 129
18.3 Partnerships 131
18.3.1 The
Medcan Clinic Enters into an Agreement with PGXL laboratories 131
18.3.2
Newfound Genomics Enters Into An Agreement With Genesis Group 132
18.3.3
Assay Designs Signs An Agreement With Abnova 133
18.3.4 Miraculins Signs A
Licensing Agreement With Mount Sinai Hospital 134
18.3.5 Warnex Signs An
Agreement With GENDIA 135
18.3.6 Exiqon And Roche Diagnostics Enter Into
Partnership 136
19 Recent Developments 137
19.1 Product News 137
19.1.1 Mar 11, 2009: Cepheid' s Xpert MRSA/SA Blood Culture (BC) Test Receives
Health Canada License 137
19.1.2 Mar 10, 2009: ArcticDx Inc. Launches
Macula Risk Genetic Test For Age-Related Macular Degeneration 137
19.1.3
Jan 22, 2009: Miraculins Announces Successful Completion Of Testing Of P2V
Immunoassay 137
19.1.4 Jan 13, 2009: Invitrogen Announces Health Canada
Approval For DynaChip HLA Antibody Analysis System 138
19.1.5 Dec 18,
2008: Evaluation Of WavSTAT During Colonoscopies 138
19.1.6 Nov 13, 2008:
Perceptronix to Exhibit at Toronto Academy of Dentistry Annual Winter Clinic
139
19.1.7 Nov 10, 2008: LungSign Study To Monitor Lung Cancer Recurrence
139
19.1.8 Oct 08, 2008: Luminex Corporation Receives Clearance From
Health Canada For xTAG Respiratory Viral Panel 139
20 Appendix 141
20.1 Global Markets Direct Research Methodology 141
20.2 Coverage 142
20.3 Secondary Research 142
20.4 Primary Research 143
20.5 Models
143
20.6 Forecasts 144
20.7 Expert Panel Validation 144
20.8
Currency Conversion 145
20.9 Contact Us 146
20.10 Disclaimer 146
1.1 List of Tables
Table 1: Number of Physicians by Province in
Canada, 2001 and 2005 25
Table 2: Hospital Wards by Specialty in Canada,
2003-2007 26
Table 3: Doctors by Specialty in Canada, 2003-2007 27
Table 4: Canada Healthcare Trade Statistics, 2001-2006 29
Table 5: Medical
Equipment Classification in Canada, 2007 30
Table 6: Medical Equipment
Licensing Fee in Canada, 2007 33
Table 7: Medical Equipment License
Processing Duration in Canada, 2007 33
Table 8: In Vitro Diagnostics,
Canada, Overall Revenue ($ mn), 2000-2015 37
Table 9: In Vitro
Diagnostics, Canada, Cross-Category Analysis, 2000-2015 38
Table 10:
In Vitro Diagnostics, Canada, Overall Revenue ($ mn), Historic, 2000-2008
40
Table 11: In Vitro Diagnostics, Canada, Overall Revenue ($ mn),
Forecast, 2008-2015 42
Table 12: In Vitro Diagnostics, Canada,
Company Share by Revenue ($ mn), 2006-2007 43
Table 13: Blood Test
Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2008 45
Table
14: Blood Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast,
2008-2015 47
Table 15: Haematology Test Reagents, Canada, Revenue ($
mn) by Sub-Segment, Historic, 2000-2008 48
Table 16: Haematology Test
Reagents, Canada, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 49
Table 17: Hemostasis Test Reagents, Canada, Revenue ($ mn) by
Sub-Segment, Historic, 2000-2008 50
Table 18: Hemostasis Test
Reagents, Canada, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 51
Table 19: Blood Test Reagents, Canada, Distribution Share by Revenue
($mn), 2007-2008 52
Table 20: Blood Test Reagents, Canada, Company
Share by Revenue ($ mn), 2006-2007 53
Table 21: Clinical Chemistry
Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2008 54
Table 22: Clinical Chemistry Test Reagents, Canada, Revenue ($ mn) by
Segment, Forecast, 2008-2015 55
Table 23: Clinical Chemistry Test
Reagents, Canada, Distribution Share by Revenue ($mn), 2007-2008 56
Table
24: Clinical Chemistry Test Reagents, Canada, Company Share by Revenue ($
mn), 2006-2007 57
Table 25: Genetic Test Reagents, Canada, Revenue ($
mn), Historic, 2000-2008 58
Table 26: Genetic Test Reagents, Canada,
Revenue ($ mn), Forecast, 2008-2015 59
Table 27: Genetic Test
Reagents, Canada, Distribution Share by Revenue ($mn), 2007-2008 60
Table
28: Genetic Test Reagents, Canada, Company Share by Revenue ($ mn),
2006-2007 61
Table 29: Immunochemistry Test Reagents, Canada, Revenue
($ mn) by Segment, Historic, 2000-2008 63
Table 30: Immunochemistry
Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2008-2015 65
Table 31: Disease Specific Markers, Canada, Revenue ($ mn) by
Sub-Segment, Historic, 2000-2008 66
Table 32: Disease Specific
Markers, Canada, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 67
Table 33: Disease Specific Test Reagents, Canada, Revenue ($ mn) by
Sub-Segment, Historic, 2000-2008 68
Table 34: Disease Specific Test
Reagents, Canada, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 69
Table 35: Drug Related Testing Reagents, Canada, Revenue ($ mn) by
Sub-Segment, Historic, 2000-2008 70
Table 36: Drug Related Testing
Reagents, Canada, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 71
Table 37: Hormone Related Testing Reagents, Canada, Revenue ($ mn) by
Sub-Segment, Historic, 2000-2008 72
Table 38: Hormone Related Testing
Reagents, Canada, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 73
Table 39: Immunochemistry Test Reagents, Canada, Distribution Share by
Revenue ($mn), 2007-2008 74
Table 40: Immunochemistry Test Reagents,
Canada, Company Share by Revenue ($ mn), 2006-2007 75
Table 41:
Infectious Immunology Test Reagents, Canada, Revenue ($ mn) by Segment,
Historic, 2000-2008 77
Table 42: Infectious Immunology Test Reagents,
Canada, Revenue ($ mn) by Segment, Forecast, 2008-2015 79
Table 43:
Virology, Canada, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 80
Table 44: Virology, Canada, Revenue ($ mn) by Sub-Segment, Forecast,
2008-2015 81
Table 45: Infectious Immunology Test Reagents, Canada,
Distribution Share by Revenue ($mn), 2007-2008 82
Table 46:
Infectious Immunology Test Reagents, Canada, Company Share by Revenue ($ mn),
2006-2007 83
Table 47: Instruments, Canada, Revenue ($ mn), Historic,
2000-2008 84
Table 48: Instruments, Canada, Revenue ($ mn), Forecast,
2008-2015 85
Table 49: Instruments, Canada, Distribution Share by
Revenue ($mn), 2007-2008 86
Table 50: Microbiology Test Reagents
(Bacteriology Test Reagents), Canada, Revenue ($ mn), Historic, 2000-2008
87
Table 51: Microbiology Test Reagents (Bacteriology Test Reagents),
Canada, Revenue ($ mn), Forecast, 2008-2015 88
Table 52: Bacteriology
Test Reagents, Canada, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
89
Table 53: Bacteriology Test Reagents, Canada, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 90
Table 54: Microbiology Test
Reagents, Canada, Distribution Share by Revenue ($mn), 2007-2008 91
Table
55: Self Testing, Canada, Revenue ($ mn), Historic, 2000-2008 92
Table 56: Self Testing, Canada, Revenue ($ mn), Forecast, 2008-2015
93
Table 57: Self Testing, Canada, Distribution Share by Revenue
($mn), 2007-2008 94
Table 58: Self Testing, Canada, Company Share by
Revenue ($ mn), 2006-2007 95
Table 59: Beckman Coulter, Inc. Pipeline
Products by Equipment Type 105
Table 60: Beckman Coulter, Inc.
Pipeline Products By Development Stage 106
Table 61: Beckman Coulter,
Inc. Pipeline Products By Therapy Area 106
Table 62: Beckman Coulter,
Inc. Pipeline Products By News Summary 107
Table 63: Ortho-Clinical
Diagnostics Inc. Pipeline Products by Equipment Type 117
Table 64:
Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage 117
Table 65: Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy
Area 118
Table 66: Ortho-Clinical Diagnostics Inc. Pipeline Products
By News Summary 118
Table 67: Gen-Probe Incorporated Pipeline
Products by Equipment Type 123
Table 68: Gen-Probe Incorporated
Pipeline Products By Development Stage 123
Table 69: Gen-Probe
Incorporated Pipeline Products By Therapy Area 124
Table 70:
Gen-Probe Incorporated Pipeline Products By Clinical Trials 124
Table 71:
Gen-Probe Incorporated Pipeline Products By News Summary 124
Table 72:
Pacgen Biopharmaceuticals Terminates Merger Agreement With Medigen
Biotechnology 126
Table 73: Cytognomix Receives Investment From
Ontario Genomics Institute 127
Table 74: JAG Media Holdings To
Acquire CardioGenics From Yahia Gawad 128
Table 75: Amorfix Life
Sciences Receives Investment From Biogen Idec 129
Table 76: The
Medcan Clinic Enters Into An Agreement With PGXL laboratories 131
Table
77: Newfound Genomics Enters Into An Agreement With Genesis Group 132
Table 78: Assay Designs Signs An Agreement With Abnova 133
Table 79:
Miraculins Signs A Licensing Agreement With Mount Sinai Hospital 134
Table 80: Warnex Signs An Agreement With GENDIA 135
Table 81:
Exiqon And Roche Diagnostics Enter Into Partnership 136
Table 82: USD to
Local Currency, Average Exchange Rate 2008 145
1.2 List of
Figures
Figure 1: Healthcare Financing in Canada, 2004 23
Figure 2:
Healthcare Expenditure in Canada, 2000 - 2006 24
Figure 3: In Vitro
Diagnostics, Canada, Overall Revenue ($ mn), 2000-2015 37
Figure 4:
In Vitro Diagnostics, Canada, Cross-Category Analysis, 2000-2015 38
Figure
5: In Vitro Diagnostics, Canada, Overall Revenue ($ mn), Historic,
2000-2008 39
Figure 6: In Vitro Diagnostics, Canada, Overall Revenue
($ mn), Forecast, 2008-2015 41
Figure 7: In Vitro Diagnostics,
Canada, Company Share (%), 2007 43
Figure 8: Blood Test Reagents,
Canada, Revenue ($ mn) by Segment, Historic, 2000-2008 44
Figure 9:
Blood Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2008-2015
46
Figure 10: Haematology Test Reagents, Canada, Revenue ($ mn) by
Sub-Segment, Historic, 2000-2008 48
Figure 11: Haematology Test
Reagents, Canada, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 49
Figure 12: Hemostasis Test Reagents, Canada, Revenue ($ mn) by
Sub-Segment, Historic, 2000-2008 50
Figure 13: Hemostasis Test
Reagents, Canada, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 51
Figure 14: Blood Test Reagents, Canada, Company Share (%), 2007 53
Figure 15: Clinical Chemistry Test Reagents, Canada, Revenue ($ mn) by
Segment, Historic, 2000-2008 54
Figure 16: Clinical Chemistry Test
Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2008-2015 55
Figure
17: Clinical Chemistry Test Reagents, Canada, Company Share (%), 2007
57
Figure 18: Genetic Test Reagents, Canada, Revenue ($ mn),
Historic, 2000-2008 58
Figure 19: Genetic Test Reagents, Canada,
Revenue ($ mn), Forecast, 2008-2015 59
Figure 20: Genetic Test
Reagents, Canada, Company Share (%), 2007 61
Figure 21:
Immunochemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Historic,
2000-2008 62
Figure 22: Immunochemistry Test Reagents, Canada,
Revenue ($ mn) by Segment, Forecast, 2008-2015 64
Figure 23: Disease
Specific Markers, Canada, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
66
Figure 24: Disease Specific Markers, Canada, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 67
Figure 25: Disease Specific Test
Reagents, Canada, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 68
Figure 26: Disease Specific Test Reagents, Canada, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 69
Figure 27: Drug Related Testing
Reagents, Canada, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 70
Figure 28: Drug Related Testing Reagents, Canada, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 71
Figure 29: Hormone Related
Testing Reagents, Canada, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
72
Figure 30: Hormone Related Testing Reagents, Canada, Revenue ($
mn) by Sub-Segment, Forecast, 2008-2015 73
Figure 31: Immunochemistry
Test Reagents, Canada, Company Share (%), 2007 75
Figure 32:
Infectious Immunology Test Reagents, Canada, Revenue ($ mn) by Segment,
Historic, 2000-2008 76
Figure 33: Infectious Immunology Test
Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2008-2015 78
Figure
34: Virology, Canada, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
80
Figure 35: Virology, Canada, Revenue ($ mn) by Sub-Segment,
Forecast, 2008-2015 81
Figure 36: Infectious Immunology Test
Reagents, Canada, Company Share (%), 2007 83
Figure 37: Instruments,
Canada, Revenue ($ mn), Historic, 2000-2008 84
Figure 38:
Instruments, Canada, Revenue ($ mn), Forecast, 2008-2015 85
Figure 39:
Microbiology Test Reagents (Bacteriology Test Reagents), Canada, Revenue ($
mn), Historic, 2000-2008 87
Figure 40: Microbiology Test Reagents
(Bacteriology Test Reagents), Canada, Revenue ($ mn), Forecast, 2008-2015
88
Figure 41: Bacteriology Test Reagents, Canada, Revenue ($ mn) by
Sub-Segment, Historic, 2000-2008 89
Figure 42: Bacteriology Test
Reagents, Canada, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 90
Figure 43: Self Testing, Canada, Revenue ($ mn), Historic, 2000-2008
92
Figure 44: Self Testing, Canada, Revenue ($ mn), Forecast,
2008-2015 93
Figure 45: Self Testing, Canada, Company Share (%), 2007
95
Figure 46: F. Hoffmann-La Roche Ltd Value Chain Analysis 97
Figure 47: Abbott Laboratories Value Chain Analysis 100
Figure 48:
Beckman Coulter, Inc. Value Chain Analysis 103
Figure 49: Siemens
Medical Solutions Value Chain Analysis 110
Figure 50: Biomerieux Sa
Value Chain Analysis 113
Figure 51: Gen-Probe Incorporated Value
Chain Analysis 121
Figure 52: Global Markets Direct Methodology
141
|
Related Report
|
View Cart
